In mammals, leucocytes of the adaptive and innate immune systems must move from their sites of origin to sites of maturation, or to where they are deployed against the invasion of pathogens. The vascular tree serves as the primary throughfare by which leucocytes move to these various destinations. Adhesion must be established between the leucocyte and the endothelial cells that line the vascular tree to enable leucocytes to escape the vascular compartment and then contribute to extravascular immune processes. A major fraction of these leucocyte-endothelial-cell adhesive events initiate with, and require interactions between, the selectin family of cell adhesion molecules and their glycoconjugate counter-receptors. This article will review the structures of the glycan components of these counter-receptors, and the glycosyltransferases that control their expression.
Introduction
The use of molecular cloning during the last 15 years has begun to provide a glimpse at the protein and corresponding DNA sequences of the enzymes that control glycan structure and function in mammals. Generally speaking, glycan structural diversity is regulated during developmental processes and shows lineage specificity in the adult animal. This diversity is determined largely by transcriptional control of the glycosyltransferases that are responsible for glycoconjugate synthesis [1] . A consideration of the glycan structures themselves, as well as emerging information about expression patterns of the various glycosyltransferases involved in their synthesis, allows one to assign glycosyltransferases and their cognate glycosidic bonds to two general types (Figure 1 ). The first type is classified based on glycan moieties, and the corresponding glycosyltransferases that are constitutively expressed in most or even all cell types in the mammalian organism. These glycan structures represent, to some extent, a platform upon which the second type of glycosyltransferases operate. Members of this type are often expressed with developmental and lineage specificity, and can thus yield glycan structures that are found only in some cell types, and/or only at certain stages of development in mammals. Both types of glycosyltransferases and the corresponding glycans are essential to the elaboration of glycoprotein counter-receptors for the selectin family of cell adhesion molecules, and in the control of selectin-dependent leucocyte-trafficking events in mammals [2] . This chapter reviews the current understanding of the glycan structures that contribute to selectin counter-receptor activity, with an emphasis on the glycosyltransferase genes that control the synthesis of these oligosaccharides, and on genomic approaches that have helped to identify and characterize these genes.
As reviewed elsewhere, the selectin family of cell adhesion molecules comprises three molecules: E-selectin, P-selectin and L-selectin [2, 3] . These are type 1 transmembrane proteins, each of which has an N-terminal carbohydrate recognition domain. E-selectin expression is generally restricted to vascular Figure 1 Constitutive and regulated glycosyltransferases. Prototypical asparagine-linked glycans, serine/threonine-linked glycans and lipid-linked glycans are shown. Enzymes that account for the synthesis of the glycosidic bonds closest to the plasma membrane are more likely to be constitutively expressed in many or even all tissues. In contrast, temporal regulation of expression during development and lineage specificity of restriction are more typical of glycosidic bonds, and the corresponding glycosyltransferases at the more distal reaches of these types of mammalian glycans. See text for additional discussion.
endothelial cells, is induced under the influence of cytokines like tumour necrosis factor ␣ and interleukin 1␤, and recognizes sialylated, fucosylated glycoprotein and glycolipid counter-receptors on leucocytes. Inflammatory stimuli induce expression of P-selectin by vascular endothelial cells; acutely by liberation from preformed P-selectin molecules stored in Weibel-Palade bodies, and subacutely after transcriptional induction. P-selectin is also elaborated by platelets after platelet activation. Leucocyte counter-receptors for P-selectin are, like E-selectin counter-receptors, sialylated and fucosylated glycoconjugates [2] . Recruitment of neutrophils, monocytes, eosinophils and specific lymphocyte subsets to extravascular inflammatory sites is, in most instances, essentially dependent upon E-selectin-and P-selectin-dependent adhesion interaction with the glycoconjugate counter-receptors on leucocytes. In the context of shear forces within the vasculature, E-selectin-and P-selectindependent leucocyte adhesion captures free-flowing leucocytes, and mediates leucocyte rolling under shear. Activational events caused by cytokines from the vascular wall activate the rolling leucocytes, yielding inside-out signalling events that lead to leucocyte integrin activation, firm adhesion to the endothelial cell lining of the vascular wall via integrin-dependent adhesion, followed by transleucocyte migration. L-selectin, which is expressed by most types of blood leucocytes, also contributes to this process, either by displaying counterreceptor activity for E-selectin, or by recognizing glycoconjugate counter-receptors expressed by activated vascular endothelia. This multi-step paradigm has been reviewed in [2, 3] .
A distinct leucocyte trafficking process, termed lymphocyte homing, is, by contrast, mediated exclusively by L-selectin-dependent adhesion. Lymphocyte homing is the process by which T-and B-lymphocytes are recruited from the blood into the parenchyma of lymph nodes and Peyer's patches. Lymphocyte-borne L-selectin mediates lymphocyte rolling on specialized postcapillary endothelial vessels -high-endothelial venules (HEVs) -in these secondary lymphoid organs via interactions with specific sialylated, fucosylated, sulphated mucin-type L-selectin counter-receptors that are expressed by the endothelial cells of the HEVs. As with E-selectin-and Pselectin-dependent leucocyte recruitment and inflammation, L-selectindependent lymphocyte homing is characterized by lymphocyte rolling under shear, followed by integrin activation, integrin-dependent firm adhesion and lymphocyte transmigration to the parenchyma of the node. This paradigm, in the context of lymphocyte homing, has been reviewed in [3, 4] .
L-selectin ligands required for lymphocyte homing
The molecular details of L-selectin glycoconjugate counter-receptors on HEVs, and the corresponding glycosyltransferase genes that are necessary for their synthesis, are understood in substantial detail. These are discussed first to provide a conceptual framework for the subsequent discussion of E-selectin and P-selectin counter-receptor biosynthesis in leucocytes, for which there are many strong parallels, but where there is a less extensive and precise understanding of the enzymes and structures involved.
Initial clues as to the glyconjugate nature of L-selectin counter-receptors derived from studies by Rosen's group, which demonstrated a requirement for sialylation and sulphation in the interaction between L-selectin and its counterreceptors (reviewed in [4] ). A role for fucosylation in L-selectin counter-receptor activity was suggested by the identification of fucose as a component of L-selectin counter-receptors [5] , by a requirement for ␣1-3fuco-sylation in E-selectin and P-selectin counter-receptor activity in vitro [2, 6] and by a requirement for ␣1-3fucosylation in lymphocyte homing and L-selectin ligand activity in vivo [6] . Armed with the knowledge that L-selectin counterreceptor activity required sulphation, sialylation and ␣1-3fucosylation, glycan structure analyses were initiated to define, at a molecular level, the structures of the glycans required for L-selectin counter-receptor activity [7] [8] [9] . These analyses provided evidence for the existence of one or more specific sialylated, sulphated, fucosylated, glycan 'capping' groups associated with L-selectin counter-receptors purified from mouse HEVs (Figure 2 ). These studies represented an important starting point for identifying the genes required for the synthesis of these glycans, the order of their assembly and their specific contributions to L-selectin-dependent cell adhesion. 
Sulphotransferases in L-selectin ligand synthesis
These capping groups were characterized by the presence of sulphate at the C-6 position of the galactose residue within the tetrasaccharide capping group, and sulphate at the C-6 position of the N-acetylglucosamine (GlcNAc) residue within this moiety. As discussed elsewhere, biochemical and genetic evidence support a biosynthetic scheme for the generation of these proposed capping groups, starting with sulphation of glycan precursors, followed by ␣2-3sialylation, and then ␣1-3fucosylation [4, 10] , yet the nature of the sulphotransferase(s) required for construction of these capping groups had not been defined. Molecular cloning efforts had previously identified a sulphotransferase gene responsible for 6-O-galactose sulphation in keratin sulphate biosynthesis [11] , and a related sulphotransferase gene encoding a 6-O-GalNAc sulphotransferase involved in chondroitin sulphate biosynthesis [12] . Biochemical studies with these enzymes indicate that both enzymes can add sulphate at the C-6 position of the galactose moiety on ␣2-3sialyl-N-acetyl-lactosamine with a low efficiency [11, 12] . These considerations, together with weak primary sequence similarities among the catalytic domains of several sulphotransferases, prompted two groups to use segments of these genes to search human and mouse sequence databases for related, candidate sulphotransferases corresponding to those involved in L-selectin counter-receptor sulphation. In one instance, these efforts identified a cDNA encoding a protein termed L-selectin ligand sulphotransferase (LSST), a predicted type 2 transmembrane protein that is typical of mammalian glycosyltransferases [13] . In another instance, the human version of this sequence, which was called high endothelial cell (HEC)-GlcNAc-6-sulphotransferase, was cloned [14] . Both groups also studied a second enzyme exhibiting GlcNAc-6-sulphotransferase activity. These enzymes are representative of a family of galactose/N-acetylgalactosamine/GlcNAc 6-O-sulphotransferases (GSTs). These enzymes, their substrate specificities, nomenclature and chromosomal localization have been reviewed [4, 15] .
In vitro studies have implied that one member of this family, termed GST-3 (formerly known as LSST or HEC-GlcNAc-6-sulphotransferase), is likely to have the most direct relevance to L-selectin ligand carbohydrate sulphation [13, 14, 16] . These studies show that GST-3 transcripts localize primarily to HECs, which is consistent with a role in the expression of Lselectin ligands by HEVs. In cultured cells that have been transfected with the mucin-type glycoprotein CD34, together with a core 2 GlcNAc transferase (Core-2-GlcNAcT) and the ␣1-3fucosyltransferase FucT-VII, L-selectin ligand activity is clearly GST-3-dependent, as assessed by flow cytometry experiments using an L-selectin-Ig chimaera, or by cell adhesion assays under shear. Biochemical analyses indicate clearly that this enzyme catalyses the transfer of sulphate from the sulphation donor adenosine 3Ј-phosphate 5Ј-phosphosulphate to the 6-hydroxyl of the GlcNAc moiety on core-2-type O-glycans within the context of the sialyl Lewis x tetrasaccharide. Considered together, observations from both groups provide strong evidence that GST-3 is responsible for synthesis of the 6-sulpho sialyl Lewis x determinant on L-selectin counter-receptors that include CD34, glycosylation-dependent cell adhesion molecule 1 (GlyCAM-1) and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) [13, 14, 16] .
A role for this enzyme in the control of L-selectin ligand activity on HEVs has been demonstrated recently through the construction and analysis of a strain of mice with an induced null mutation in the GST-3 locus [17] . These studies showed that deletion of GST-3 yields a substantial reduction in Lselectin ligand activity on peripheral node HEVs, including loss of binding of an L-selectin-Ig chimaera to the luminal face of the HEV. The loss of binding correlates with a substantial decrease in homing of lymphocytes to the peripheral nodes, as well as a decrease in the steady state level of lymphocytes that can be recovered from the peripheral nodes. Considered together, these results assign GST-3 to a pivotal role in the elaboration of L-selectin ligand activities displayed by peripheral node HEVs, and that decorate the HEV-expressed Lselectin counter-receptor molecules CD34, GlyCAM-1 and other mucin-type glycoproteins. Interestingly, the GST-3 null mice appear to retain residual Lselectin ligand activity expressed by the luminal aspects of their HEVs in peripheral nodes, indicating the existence of GST-3-independent L-selectin ligand activities. It remains to be determined if these residual GST-3-independent activities are sulphation-dependent, and the nature of the glycan structures that account for these residual activities remains to be defined.
Core-2 and Core-1 O-glycans in L-selectin ligand activity
As is implied above, glycan structural analyses provide evidence for a contribution to the synthesis of glycans associated with L-selectin ligand activity by a ␤1-6GlcNAcT enzyme activity that is generically referred to as Core-2-GlcNAcT. This enzyme creates a core 2 branch on O-glycans, and, as noted above, GST-3 activity is apparently optimal with core 2 branched O-glycans. Furthermore, as reviewed elsewhere [3] , core 2 O-glycans had been assigned an essential role in P-selectin counter-receptor activity in experiments where such activity was reconstituted in transfected cell lines in vitro. To assess the functional relevance of this enzyme in selectin ligand activity in vivo, a gene targeting approach has been used to construct a strain of mice that is deficient in a Core-2-GlcNAcT [18] . Subsequent to the creation and analysis of this mouse, additional molecular cloning work identified a family of three distinct Core-2-GlcNAcT loci, which corresponded to enzymes that are now termed Core-2-GlcNAcT-I, Core-2-GlcNAcT-II and Core-2-GlcNAcT-III [19, 20] . The Core-2-GlcNAcT locus that was disabled in these knockout mouse studies corresponds to Core-2-GlcNAcT-I. Analysis of lymphocyte homing in the Core-2-GlcNAcT-I null mice reveals essentially normal lymphocyte homing to peripheral nodes, as well as to mesenteric nodes and Peyer's patches, and virtually normal accumulation of lymphocytes in the nodes [18] . A modest decrease in L-selectin ligands on peripheral node HEVs was observed, using immunohistochemistry and an L-selectin-IgM chimaera, in the null animals. These observations suggested that deletion of Core-2-GlcNAcT-I yields a subtle quantitative or qualitative decrease in L-selectin ligand reactivity that is not accompanied by a physiologically apparent lymphocyte homing defect.
The virtually normal L-selectin ligand activity in Core-2-GlcNAcT-I null animals could, in principle, be ascribed to expression of other Core-2-GlcNAcTs, or to L-selectin ligand activities that do not require Core-2-GlcNAcT activity. These alternative possibilities have been distinguished subsequently by analysis of the glycans expressed by the HEVs in Core-2-GlcNAcT-I null mice [21] . These studies disclose an absence of any core 2-type O-glycan structures among sulphated, sialylated radiolabelled Oglycans that were isolated from the HEVs of Core-2-GlcNAcT-I null mice, and thus exclude the possibility that other Core-2-GlcNAcT activities account for, more or less, normal L-selectin-dependent homing activities in Core-2-GlcNAcT-I null mice. Importantly, structural analyses of glycans expressed by the HEVs of Core-2-GlcNAcT-I null mice disclosed the existence of extended core 1-type O-linked glycans associated with HEV-derived mucin-type glycoproteins, and bearing the 6-sulpho sialyl Lewis x structure. These observations predicted the existence of a corresponding Core-1-␤3GlcNAcT.
Previous work demonstrated modest sequence similarities between a ␤3GlcNAc-T and three ␤1-3-galactosyltransferases, each of which exhibited some limited aspects corresponding to the requisite Core-1-␤3GlcNAcT activity [22] . Searches of DNA sequence databases were initiated to identify candidate cDNAs corresponding to such an activity [21] . These efforts yielded a human DNA sequence whose corresponding transcripts localize to HEVs, as was expected for its possible role in the synthesis of L-selectin ligands. Its fulllength cDNA is predicted to encode a protein with a type 2 transmembrane topology. A soluble fusion protein derivative of this candidate Core-1-␤3GlcNAcT was observed to add GlcNAc to a low-molecular-mass core 1 glycan analogue (Gal␤1-3GalNAc␣1-R) to form the core 1 branch, and was also observed to add GlcNAc to a low-molecular-mass core 2 acceptor substrate [Gal␤1-3(GlcNAc␤1-6)GalNAc␣1-R]. Furthermore, reconstitution experiments using Chinese hamster ovary cells that express GlyCAM-1 or CD34, GST-3 and Fuc-TVII, with either Core-1-␤3GlcNAcT, Core-2-GlcNAcT-I or both enzymes, disclose that expression of Core-1-␤3GlcNAcT or of Core-2-GlcNAcT-I enhances L-selectin ligand activity of the transfected Chinese hamster ovary cells, as assessed by lymphocyte rolling under shear. By contrast, co-expression of Core-1-␤3GlcNAcT plus Core-2-GlcNAcT-I yields an additive, and possibly synergistic, contribution to L-selectin ligand activity in this in vitro system. Glycan structural analyses to develop a molecular correlate for these adhesion studies identify bi-antennary O-glycans containing 6-sulpho sialyl Lewis x on both the core 1 extension and on the core 2 branch. These observations indicate that both enzymes have important roles in wild-type HEVs. This work also suggests that, among the known 6-sulpho sialyl Lewis x -type glycans expressed by peripheral node HEVs, the bi-antennary-type 6-sulpho sialyl Lewis x structures may provide the most prominent contribution to L-selectin ligand activity, relative to 6-sulpho sialyl Lewis xsubstituted mono-antennary-type structures. Manipulation of the extended core 1 structures, via targeted deletion of the locus in mice, will help to define more precisely the functional relevance of Core-1-␤3GlcNAcT in the expression of L-selectin ligands in HEVs.
Work in this paper also identified the molecular nature of the glycan epitope recognized by the MECA-79 monoclonal antibody. The MECA-79 antibody has been known for many years to recognize the luminal surface of peripheral node HEVs [23] , and has been used widely to inhibit attachment of lymphocytes to HEVs in vitro and in vivo [23] and to isolate L-selectin ligands biochemically [24] ; it has also been known to recognize sulphated O-glycans [25] . Nevertheless, the precise structural requirements for its recognition were not clear. Yeh et al. [21] firmly established that the MECA-79 epitope corresponds to the 6-sulphated, extended core 1 glycan Gal␤1-4[6-sulpho]GlcNAc␤1-3Gal␤1-3GalNAc␣1.
Fucosylation in the control of L-selectin ligand activity
A contribution by ␣1-3fucosylation to the function of L-selectin counter-receptors was suggested by studies published in the early 1990s that identified a requirement for this modification for E-selectin and P-selectin counter-receptors (reviewed in [2] ), and by the strong primary sequence similarity shared by the carbohydrate-recognition domains of E-, P-and L-selectins. Evidence to support the requirement for this modification for Lselectin ligand activities in vivo derives from the study of mice that were homozygous for a null mutation at an ␣1-3fucosyltransferase locus that is expressed in HEVs [26] and termed FucT-VII [6] . HEVs of the peripheral nodes in these mice do not bind an L-selectin-IgM chimaera and there is an approx. 80-90% reduction in the number of lymphocytes that can be recovered from the peripheral nodes of these animals, with a quantitatively corresponding defect in lymphocyte homing. These observations, together with in vitro studies indicating that FucT-VII can utilize 6-O-sulphated ␣2-3sialylated lactosamine precursors, implied that FucT-VII contributes to the synthesis of the 6-sulpho sialyl Lewis x moiety discussed above.
The contribution of FucT-VII to L-selectin ligand synthesis in cultured cells is well established. In these studies, L-selectin ligands have been reconstituted through transfection with FucT-VII, glycoprotein 'scaffolds' like GlyCAM-1 or CD34, sulphotransferase cDNAs (including GST-3) and Core-2-GlcNAcT-I, while taking advantage of endogenous ␣2-3sialyltransferase activities [13, 14, 16, 21, 27] . These studies, and observations made in FucT-VII null mice, indicated that this enzyme is a primary participant in controlling Lselectin counter-receptor activity. Nevertheless, the peripheral nodes in FucT-VII null mice are not small, as had been observed in mice homozygous for null alleles at the L-selectin locus [27] , and the nodes from FucT-VII null mice had some residual L-selectin-dependent lymphocyte homing activity. These considerations implied either that fucosylation-independent L-selectin ligand activities exist, or that another fucosyltransferase contributed to the residual activities. This uncertainty has been resolved with analysis of mice with deficiency of both FucT-VII and a second ␣1-3fucosyltransferase termed FucT-IV [10] . These mice have extremely small peripheral lymph nodes, akin to those observed in L-selectin null mice. The residual lymphocyte homing observed in the FucT-VII null mice is essentially abolished in the FucT-IV Ϫ/Ϫ /FucT-VII Ϫ/Ϫ double-deficient mice, and their peripheral nodes are virtually devoid of naïve T-lymphocytes [28] , a category of T-cells that require L-selectin for homing to peripheral lymph nodes [29] . By contrast, lymphocyte homing and peripheral node phenotypes in mice with a FucT-IV deficiency alone were essentially indistinguishable from those of wild-type mice.
Shear-dependent cell adhesion correlates for each of these phenotypes have been developed using in vitro shear-dependent cell adhesion assays. These assays take advantage of the fact that GlyCAM-1 is a membrane-associated, HEV-derived protein that is released into the circulation, and can be purified from the serum of mice [30] . Wild-type GlyCAM-1 and GlyCAM-1 from FucT-IV null mice, FucT-VII null mice and FucT-IV Ϫ/Ϫ /FucT-VII Ϫ/Ϫ mice were purified from the serum of these mice and were attached to the bottom surface of a parallel plate flow chamber at two different densities. Wild-type mouse lymphocytes were then passed over this L-selectin counter-receptorcoated surface under physiologically relevant shear forces, and lymphocyte tethering events were captured by videomicroscopy and quantitated. These experiments demonstrated similar tethering activities of GlyCAM-1 isolated from wild-type and FucT-IV null mice however, they demonstrated a substantial decrease in tethering activity using GlyCAM-1 from FucT-VII null mice, and no detectable tethering using GlyCAM-1 isolated from the serum of the FucT-IV Ϫ/Ϫ /FucT-VII Ϫ/Ϫ mice [10] . Considered together, these observations indicate that FucT-VII plays a much more prominent role than FucT-IV in the fucosylation of functionally relevant L-selectin counter-receptors. A possible role of FucT-IV is revealed only when FucT-VII is absent. Enzymic correlates for these observations, developed using low-molecular-mass precursors for some of the molecules in depicted Figure 2 suggest that FucT-VII contributes to the synthesis of 6-sulpho sialyl Lewis x determinants and sialyl Lewis x determinants, whereas FucT-IV may contribute to the synthesis of non-sialylated isomers of these molecules. Structurally related molecules are known to support L-selectin-dependent adhesion in vitro [31] ; however, it remains to be determined if non-sialylated, 6-O-sulphated, ␣1-3fucosylated molecules are found in HEVs in vivo. It is also not known if such molecules are present in amounts that make meaningful contributions to L-selectin ligand activity and the lymphocyte homing process, and whether they may be increased in the absence of FucT-VII. Structural analysis of GlyCAM-1-associated glycans from the three different fucosyltransferase strains is in progress in order to address these issues. Future work to more precisely define the structures and biosynthesis of L-selectin ligands will most likely focus on defining glycan structures in mice with induced null mutations in new sulphotransferase and ␣2-3sialyltransferase loci that may participate in the synthesis of such glycans.
Glycosylation in the control of P-and E-selectin activity
Strong similarities exist between the glycosylation pathways that determine L-selectin counter-receptor activities and those required for E-selectin and P-selectin counter-receptor function, although it is safe to say that at present, there is less definitive glycan structural information in this regard. Radiochemical labelling procedures using HEVs in organ culture have helped to define glycan structures that are relevant to L-selectin ligands, whereas these procedures are not as effectively applied to leucocytes like blood neutrophils, whose glycan synthetic programme is considered to be nearly quiescent.
As noted above, early work assigned a primary role to sialyl Lewis x -type glycans in E-selectin counter-receptor activity. Subsequent work identified Eselectin counter-receptor activity on some glycolipids [32] , as well as specific glycoproteins on neutrophils, monocytes, T-lymphocyte subsets and eosinophils (reviewed in [3] ). E-selectin counter-receptors on leucocytes are that presumed to or demonstrated to have sialyl Lewis x -type glycans, include L-selectin itself [33] (in humans, at least) [34] , N-glycans on ESL-1 [35] and a mucin-type glycoprotein termed PSGL-1 (P-selectin glycoprotein ligand 1; discussed in [36] ). By contrast, P-selectin counter-receptor activity on leucocytes has been ascribed largely to PSGL-1 [3, 36, 37] .
Reconstitution of P-selectin ligand activity in cultured cell lines requires PSGL-1, as well as ␣2-3sialylation, ␣1-3fucosylation, Core-2-GlcNAcT and protein tyrosine sulphation [38] [39] [40] . A detailed analysis of the O-glycan structures borne by PSGL-1 in the human promyelocytic leukaemia cell line HL-60 identifies a small set of core 2-type O-glycans bearing the sialyl Lewis x determinant [41] (Figure 3 ). These include a monofucosylated core 2-type O-glycan with a sialyl Lewis x capping group, and a multiply fucosylated polylactosamine-containing core 2 O-glycan also with a sialyl Lewis x capping group. More recent studies indicate that a tyrosine-sulphated peptide derived from the N-terminal segment of PSGL-1, when decorated with the monofucosylated core 2-type O-glycan, binds to P-selectin with an affinity equivalent to native, leucocyte-derived PSGL-1, whereas the identical tyrosine-sulphated peptide, when decorated with the multiply fucosylated isomer, is not an effective P-selectin [42] . The function of the multiply fucosylated isomer, if it has any, remains to be defined, and the stoichiometry of modification of each relevant serine/threonine residue and its contribution to binding effectiveness must be determined. It also remains to be seen whether the structures identified on the HL-60-derived PSGL-1 are representative of those on human neutrophils and other leucocytes, or on mouse leucocytes, where, as discussed below, glycosyltransferase gene deletion studies have helped to define the nature of the enzymes that direct the synthesis of E-selectin and P-selectin counter-receptor activities.
The Core-2-GlcNAcT-I null mice discussed above exhibit profound deficiency of neutrophil P-selectin ligand activity, and P-selectin-dependent cell adhesion [18] . These deficits are similar to the those observed in PSGL-1 null mice [36, 37] . By contrast, a role for Core-2-GlcNAcT-I in leucocyte Eselectin ligand activity is less clear. Depending on the nature of the approach used to study contributions by Core-2-GlcNAcT-I and/or PSGL-1 to Eselectin ligand activity, substantial or subtle defects are observed, using either Core-2-GlcNAcT-I null mice [18, 43, 44] or PSGL-1 null mice [36, 37] . Although these apparent discrepancies remain to be resolved, it seems likely that Core-2-GlcNAcT-I and/or PSGL-1 will be found to contribute substantially less to E-selectin counter-receptor activity than to that of P-selectin counter-receptor. It is interesting that Core-2-GlcNAcT-I is also implicated in the elaboration of L-selectin ligands expressed by inflammed vascular endothelium [45] . The nature of the corresponding glycans remains to be defined.
Analysis of mice with targeted deletions of the FucT-IV and FucT-VII loci indicate that the ␣1-3fucosyltransferase loci required for the synthesis of the glycans necessary for HEV-borne L-selectin ligand activity are identical to those required for P-selectin and E-selectin ligand activity. The ␣1-3fucosyl-transferase FucT-VII is expressed at high levels in bone marrow, the source of myeloid lineage cells that are typically E-selectin-ligand-and P-selectin-ligandpositive [26] . In mice that are homozygous for an induced null mutation in the FucT-VII locus, a profound diminution in E-selectin and P-selectin counterreceptor activities is observed on neutrophils and monocytes [6, 10] . Residual E-selectin and P-selectin ligand activity remains, however, as assessed in selectin-dependent inflammation models, and in shear-dependent flow chamber-based assays of neutrophil adhesion to recombinant E-and P-selectins. This residual activity is clearly FucT-IV-dependent, since the binding of neutrophils purified from FucT-IV Ϫ/Ϫ /FucT-VII Ϫ/Ϫ mice to E-or P-selectin under shear cannot be detected in vitro or in vivo, and these mice are essentially unable to recruit neutrophils to extravascular sites in E-selectin-and Pselectin-dependent inflammatory models. By contrast, FucT-IV deficiency, where the FucT-VII locus is intact, yields neutrophils whose E-selectin and Pselectin counter-receptor activities are essentially equivalent to those of wild-type neutrophils, when assayed in shear-dependent adhesion in vitro, or in E-selectin-and P-selectin-dependent inflammatory models. However, subtle defects in the rolling velocities of FucT-IV null neutrophils are observed in vivo, using intravital microscopy [46] . These observations indicate that FucT-IV contributes to neutrophil E-selectin and P-selectin ligand activities, even when FucT-VII is present.
The FucT-VII locus is also expressed by subsets of T-lymphocytes that bind to E-selectins and P-selectins, and that use E-selectin and P-selectin to migrate to sites of cutaneous inflammation [2, 28] . When isolated from FucT-VII null mice, these cells, termed memory/effector cells of the Th1 and Tc1 phenotypes [28] , neither bind to selectin in vitro nor migrate to inflammed skin in vivo [28] . In contrast, FucT-IV-deficient Th1-and Tc1-cells exhibit essentially normal E-selectin and P-selectin binding and in vivo trafficking properties. FucT-VII is thus clearly required for E-selectin and P-selectin counter-receptor activities on such cells, whereas Fuc-TIV is apparently dispensable. It remains to be seen if the small amounts of memory/effector lymphocyte trafficking observed in FucT-VII null mice is enabled by FucT-IV-dependent synthesis of E-and P-selectin counter-receptor activities.
Molecular correlates for these observations have yet be defined, and require structural analysis of the glycans borne by PSGL-1 on neutrophils, memory/effector lymphocytes and other leucocytes. The construction and analysis of Core-1-␤3GlcNAcT null mice will help determine a role for Core-1-␤3GlcNAcT in leucocyte E-and P-selectin ligand activities.
John Lowe is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by grants from the National Institutes of Health.
